Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, Maurea N. Quagliariello V, et al. Among authors: canale ml. Front Cardiovasc Med. 2022 Sep 8;9:930797. doi: 10.3389/fcvm.2022.930797. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36158826 Free PMC article.
Cardio-oncology organization patterns in Italy: one size does not fit all.
Canale ML, Lestuzzi C, Bisceglia I, Vallerio P, Parrini I; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Cardio-Oncology Task Force. Canale ML, et al. J Cardiovasc Med (Hagerstown). 2018 May;19(5):229-233. doi: 10.2459/JCM.0000000000000642. J Cardiovasc Med (Hagerstown). 2018. PMID: 29528869
Acute coronary syndromes in cancer patients.
Bisceglia I, Canale ML, Lestuzzi C, Parrini I, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Iliescu CA; on the behalf of ANMCO Cardio-Oncology Task Force. Bisceglia I, et al. Among authors: canale ml. J Cardiovasc Med (Hagerstown). 2020 Dec;21(12):944-952. doi: 10.2459/JCM.0000000000000993. J Cardiovasc Med (Hagerstown). 2020. PMID: 32520859 Review.
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Survey.
Canale ML, Turazza F, Lestuzzi C, Parrini I, Camerini A, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Oliva S, Tarantini L, Maurea N, Rigacci L, Petrolati S, Casolo G, Bisceglia I. Canale ML, et al. Front Cardiovasc Med. 2021 Jun 16;8:677544. doi: 10.3389/fcvm.2021.677544. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34222373 Free PMC article.
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
Quagliariello V, De Laurentiis M, Rea D, Barbieri A, Monti MG, Carbone A, Paccone A, Altucci L, Conte M, Canale ML, Botti G, Maurea N. Quagliariello V, et al. Among authors: canale ml. Cardiovasc Diabetol. 2021 Jul 23;20(1):150. doi: 10.1186/s12933-021-01346-y. Cardiovasc Diabetol. 2021. PMID: 34301253 Free PMC article.
ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO).
Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. Bisceglia I, et al. Among authors: canale ml. Eur Heart J Suppl. 2021 Aug 26;23(Suppl C):C128-C153. doi: 10.1093/eurheartj/suab067. eCollection 2021 Aug. Eur Heart J Suppl. 2021. PMID: 34456641 Free PMC article.
[ANMCO Position paper: Cardio-oncology in the COVID-19 era].
Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. Bisceglia I, et al. Among authors: canale ml. G Ital Cardiol (Rome). 2021 Oct;22(10):800-825. doi: 10.1714/3666.36511. G Ital Cardiol (Rome). 2021. PMID: 34570114 Italian.
65 results